New multi-drug-resistant TB regimen

A clinical trial to find a better treatment for multidrug-resistant tuberculosis (MDR-TB) stopped enrolling patients last week after its independent data safety and monitoring board indicated that the regimen being studied was superior to current treatment options. The board recommended that the trial be stopped early as more patient data was extremely unlikely to change…